Comparative study in newer techniques for management of diabetic ...

... A, Parmar H. Comparative study in newer techniques for management of diabetic foot. IAIM, 2016; 3(8):. 79-82. Page 79. Original Research Article.

Background: Diabetic foot is the commonest complication of Diabetes Mellitus. It is not totally curable or preventable but with positive approach mortality and ...

Recent Trends in Therapeutic Approaches for Diabetes Management

Recent approaches in drug discovery have contributed to the development of new class of therapeutics like Incretin mimetics, Amylin analogues, GIP analogs.

Advances in the Management of Diabetes Mellitus: A Focus on ...

This helps to reduce the likelihood of adverse drug reactions and treatment non-responsiveness [8]. The field of personalized medicine also ...

Comparative study in newer techniques for management of diabetic ...

Comparative study in newer techniques for management of diabetic foot. Desai, A; Panchal, A; Parmar, H.. Article | IMSEAR | ID: sea-186183. Key words.

Newer Pharmacologic Treatments in Adults With Type 2 Diabetes

Most included studies had shorter-term follow-up (treatment and follow-up range, 52 to 329 weeks), highlighting the need for longer-term studies ...

Comparative study of glycemic control and treatment satisfaction for ...

CONCLUSIONS:Using insulin pumps with sensors to treat patients with type 1 diabetes mellitus is superior to using multiple daily insulin injections in glycemic ...

Advances in the management of type 2 diabetes in adults

GRADE, a large scale, comparative effectiveness study of four drugs in combination with metformin, found that insulin glargine and liraglutide ...

Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018

... methods. For this analysis, we used the latest NHANES survey years (2015 through 2018) as the reference. We defined glycemic control as a ...

9. Pharmacologic Approaches to Glycemic Treatment: Standards of ...

Injectable and oral glucose-lowering drugs have been studied for their efficacy as adjuncts to insulin treatment of type 1 diabetes. Pramlintide ...

Comparative study of Dapagliflozin versus Glimepiride effect on ...

Blood samples were collected at baseline and after 3 months of treatment for biochemical analysis. Additionally, HOMA-IR is calculated. After 3 ...

Comparative Effects of Randomized Second-line Therapy for Type 2 ...

In Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) (5,047 participants, mean follow-up 5.0 years), ...

Comparative effectiveness of second line oral antidiabetic ... - The BMJ

Results 75 739 people initiated second line oral antidiabetic treatment with sulfonylureas (n=25 693, 33.9%), DPP-4 inhibitors (n=34 464 ,45.5%) ...

A comparative study of two various models of organising diabetes ...

Although the quality of care was similar, type 1 diabetic patients were more satisfied with their follow-up in the centralised system. In the ...

Second-Line Pharmaceutical Treatments for Patients with Type 2 ...

Our analysis showed that GLP1RA, SGLT2I, and DPP4I, the newer diabetes medications, were significantly associated with more effective glycemic ...

A comparative study of clinical trial and real-world data in patients ...

et al. Effect of Finerenone on chronic kidney disease outcomes in type 2 diabetes. New Eng. J. Med. 383, 2219–2229 (2020).

Type 2 Diabetes Mellitus Treatment & Management

A study comparing the efficacy and safety of monotherapy with sitagliptin or metformin in treatment-naive patients with type 2 diabetes ...

Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes

The comparative effectiveness of glucose-lowering medications for use with metformin to maintain target glycated hemoglobin levels in ...

(PDF) Diabetic: A Comparative Study - ResearchGate

PDF | p> Background and Objectives: Type II diabetes mellitus (DM) is particularly common medical disorder and is leading cause of morbidity worldwide.

Initial management of hyperglycemia in adults with type 2 diabetes ...

By study end, mean A1C was significantly lower in the intervention group (7.33 versus 7.44 percent) with less medication use and medication ...